The Generics Bulletin Top 50, Part Three: Final Firms Enjoy Mixed Fortunes

Declines See A Handful Of Players Slide Down The Chart As Others Climb Our Ranking

 
• By David Wallace
  
Generics Bulletin Top 50 2023
Off-patent firms have seen mixed fortunes in the past year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Company Rankings

More from Market Intelligence